PMID- 21188498 OWN - NLM STAT- MEDLINE DCOM- 20110617 LR - 20110309 IS - 1573-4927 (Electronic) IS - 0006-2928 (Linking) VI - 49 IP - 3-4 DP - 2011 Apr TI - Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. PG - 258-69 LID - 10.1007/s10528-010-9404-6 [doi] AB - Human leukocyte antigen (HLA) alleles have been associated with the clinical outcomes of hepatitis B virus (HBV) infection, which range from spontaneous recovery to hepatocellular carcinoma. In this study involving subjects from eastern Turkey, the frequencies of HLA-B35, HLA-CW4, HLA-DQ2, and HLA-DQ8 were markedly higher in the chronic HBV group than those in the spontaneously recovered group; the frequencies of HLA-A11 and HLA-A24 in the nonresponsive HBV vaccine group were markedly higher than those in the responsive HBV vaccine group; and the frequency of HLA-CW6 in the nonresponsive HBV vaccine group was significantly lower than in the responsive group. A complete understanding of HLA types associated with the progression to chronic HBV infection and their effects within the cell at the molecular level will be an important contribution in the development of new HBV vaccines and new treatment strategies for chronic HBV infection. FAU - Albayrak, Ayse AU - Albayrak A AD - Department of Infectious Diseases and Clinical Microbiology, Erzurum Region Education and Research Hospital, Erzurum, Turkey. aysealbayrakerz@gmail.com FAU - Ertek, Mustafa AU - Ertek M FAU - Tasyaran, Mehmet Akin AU - Tasyaran MA FAU - Pirim, Ibrahim AU - Pirim I LA - eng PT - Comparative Study PT - Journal Article DEP - 20101229 PL - United States TA - Biochem Genet JT - Biochemical genetics JID - 0126611 RN - 0 (HLA Antigens) RN - 0 (Hepatitis B Vaccines) SB - IM MH - Adult MH - Female MH - Gene Frequency MH - Genetic Association Studies MH - HLA Antigens/*genetics MH - *Hepatitis B Vaccines MH - Hepatitis B virus/*immunology MH - Hepatitis B, Chronic/*genetics/immunology/prevention & control MH - Humans MH - Male MH - Middle Aged MH - Treatment Outcome EDAT- 2010/12/29 06:00 MHDA- 2011/06/18 06:00 CRDT- 2010/12/29 06:00 PHST- 2010/02/07 00:00 [received] PHST- 2010/10/04 00:00 [accepted] PHST- 2010/12/29 06:00 [entrez] PHST- 2010/12/29 06:00 [pubmed] PHST- 2011/06/18 06:00 [medline] AID - 10.1007/s10528-010-9404-6 [doi] PST - ppublish SO - Biochem Genet. 2011 Apr;49(3-4):258-69. doi: 10.1007/s10528-010-9404-6. Epub 2010 Dec 29.